Policy & Regulations

This channel includes news coverage of healthcare policy and regulations set by Congress, the states, Centers for Disease Control and Prevention (CDC), the Department of Health and Human Services (HHS), U.S. Food and Drug Administration (FDA), and medical associations and societies. 

AMA, radiology groups ‘strongly oppose’ federal bill that would expand nurses’ authority

The Improving Care and Access to Nurses Act aims to let APRNs practice “to the full scope of their education and clinical training.” 

Thumbnail

Radiologist reaches settlement with hospital system he claimed fired him for requesting remote work

Richard Heiden, MD, has a compromised immune system and had asked NYC Health and Hospitals to reassign him to teleradiology duties after the COVID-19 pandemic hit. 

Thumbnail

New data highlight ‘massive gap’ between what Medicare, Medicaid pay for diagnostic imaging

The chasm between the two public payment programs has continued to grow since 2012, the Neiman Health Policy Institute reported recently. 

Medicare money payment

Nearing a ‘breaking point’: Cardiologists support legislation designed to mitigate Medicare cuts to office-based services

These latest cuts could be a "breaking point" for physicians, according to a new letter to lawmakers. 

Thumbnail

ACR ‘concerned’ some commercial insurers are requiring cost-sharing for USPSTF-endorsed services

The issue surfaced after a Texas district court judge declared a key Affordable Care Act provision unconstitutional in March.

Thumbnail

Whole-body MRI startup Ezra scores FDA clearance for AI tool to speed up scan times

The New York-based company now offers 30-minute “Full Body Flash” exams for $1,350, aimed at spotting disease before symptoms surface.

Thumbnail

Society of Interventional Radiology to hold legislative briefing on Capitol Hill

The event will feature Rep. Donald Payne Jr., who is chair of the Congressional Men’s Health Caucus, and focus on a cutting-edge treatment. 

Thumbnail

CMS announces coverage decision for new Alzheimer's drugs

The agency indicated that, in order for such drugs to be covered, patients with Medicare Part B must be enrolled in registries that collect real-world data on the treatment’s effectiveness.